1.
Betancor D, Valverde M, Rosado A, Gandolfo-Cano M, Robledo Echarren T, Moro-Moro M del M, et al. Benralizumab is effective in severe asthma with CRS, regardless of demographic and clinical basal outcomes. Allergol Immunopathol [Internet]. 2026 Jul. 1 [cited 2026 Jul. 1];54(4):162-6. Available from: https://all-imm.com/index.php/aei/article/view/1449